Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells

Molecular and Cellular Endocrinology

Volumn 142, Issue 1-2, 1998, Pages 57-65

  Verlinden, L ^a   Verstuyf, A ^a   Convents, R ^a   Marcelis, S ^a   Van Camp, M ^a   Bouillon, R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

1,25(OH)2D3; Breast cancer; Cyclin D1; p21; p27; TGF

Indexed keywords

COLECALCIFEROL; CYCLIN D1; PROTEIN ANTIBODY; PROTEIN P21; PROTEIN P27; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CELL PROLIFERATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CALCITRIOL; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032566140     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00117-8     Document Type: Article

References (34)

1. Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells. Oncogene. 12:1996;2315-2324.
2. 3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J. Steroid Biochem. 24:1986;373-376.
3. Colston K.W., Berger U., Coombes R.C. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. i:1989;188-191.
4. Kip1 induces cell cycle arrest and loss of cyclin-cdk activity in human breast cancer cells. Oncogene. 14:1997;2283-2289.
5. 3 analogue shows relation to promoter selectivity. J. Cell. Biochem. 66:1997;552-562.
6. Datto M.B., Yu Y., Wang X.F. Functional analysis of transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:1995;28623-28628.
7. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
8. Gao C.Y., Zelenka P.S. Cyclins, cyclin-dependent kinases and differentiation. BioEssays. 19:1997;307-315.
9. Gorospe M., Liu Y., Xu Q., Chrest F.J., Holbrook N.J. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol. Cell. Biol. 16:1996;762-770.
10. Haussler M.R., Jurutka P.W., Hsieh J.-C., Thompson P.D., Selznick S.H., Haussler C.A., Whitfield G.K. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 17:1995;33S-38S.
11. Jiang H., Lin J., Su Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3407.
12. 3 enhances antiproliferative effect and transcription of TGF-β1 on human keratinocytes in culture. J. Cell. Physiol. 151:1992;579-587.
13. Knabbe C., Lippman M.E., Wakefield L.M., Flanders K.C., Kasid A., Derynck R., Dickson R.B. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 48:1987;417-428.
14. 3 and calcipotriol enhance the secretion of transforming growth factor-β1 and -β2 in cultured murine keratinocytes. Growth Factors. 8:1993;153-163.
15. 3 enhances the expression of transforming growth factor β1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res. 55:1995;1540-1546.
16. Landesman Y., Bringold F., Milne D.D., Meek D.W. Modifications of p53 protein and accumulation of p21 and gadd45 mRNA in TGF-β1 growth inhibited cells. Cell. Signal. 9:1997;291-298.
17. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:1996;142-153.
18. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: The second decade. Cell. 83:1995;835-839.
19. Mazars P., Barboule N., Baldin V., Vidal S., Ducommon B., Valette A. Effects of TGF-β1 (transforming growth factor-β1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. FEBS Lett. 362:1995;295-300.
20. Mercier T., Chaumontet C., Gaillard-Sanchez I., Martel P., Heberden C. Calcitriol and lexicalcitol (KH1060) inhibit the growth of human breast adenocarcinoma cells by enhancing transforming growth factor β production. Biochem. Pharmacol. 52:1996;505-510.
21. Musgrove E.A., Lee S.L., Buckley M.F., Sutherland R.L. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA. 91:1994;8022-8026.
22. Musgrove E.A., Lee S.L., Cornish A.L., Swarbrick A., Sutherland R.L. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. Mol. Endocrinol. 11:1997;54-66.
23. Neuman E., Ladha M.H., Lin N., Upton T.M., Miller S.J., Direnzo J., Pestell R.G., Hinds P.W., Dowdy S.F., Brown M., Ewen M.E. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17:1997;5338-5347.
24. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59-66.
25. 3 in cultured human epidermal keratinocytes. J. Invest. Dermatol. 109:1997;46-54.
26. WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast adenocarcinoma cell lines. Oncogene. 11:1995;1899-1905.
27. Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene. 14:1997;1875-1882.
28. 3 and EB1089 on cell cycle kinetics in MCF-7 cells. Norman A.W., Bouillon R., Thomasset M. Vitamin D, A pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. 1994;506-507 Walter de Gruyter, Berlin, Germany.
29. Swinnen J.V., Esquenet M., Heyns W., Rombauts L., Verhoeven G. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP. Mol. Cell. Endocrinol. 104:1994;153-162.
30. Verhoeven G., Deboel L., Swinnen J., Rombauts L., Vanderhoydonc F., Rosseels J., Hoeben E., Heyns W. Effect of androgens on the germ cell-depleted testes of prenatally irridiated rats. Int. J. Androl. 18:1995;23-34.
31. 3 in HL-60 cells. Cancer Res. 56:1996;264-267.
32. Xiong Y., Connolly T., Futcher B., Beach D. Human D-type cyclin. Cell. 65:1991;691-699.
33. Zhou Q., Stetler-Stevenson M., Steeg P.S. Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro. Oncogene. 15:1997;107-115.
34. Zwijsen R.M.L., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R.J.A.M. Cdk-independent activation of estrogen receptor by cyclin D1. Cell. 88:1997;405-415.